Cargando…

5606726 IMPACT OF ALLOGENEIC STEM CELL TRANSPLANTATION ON PHYSICAL, MENTAL, AND SOCIAL HEALTH OF ADULT SICKLE CELL DISEASE PATIENTS: A MIXED-METHODS STUDY

Detalles Bibliográficos
Autores principales:	Dovern, E., Nijland, S.J.A., van Muilekom, M.M., Suijk, E.M.J., Hoogendoorn, G.M., Mekelenkamp, H., Biemond, B.J., Haverman, L., Nur, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112600/ http://dx.doi.org/10.1097/01.HS9.0000928192.74303.3b

Ejemplares similares

S105: ADDING AZATHIOPRINE/HYDROXYUREA PRECONDITIONING TO ALEMTUZUMAB/TBI CONDITIONING IMPROVES DONOR CHIMERISM IN MATCHED SIBLING DONOR STEM CELL TRANSPLANTATION IN ADULT SICKLE CELL DISEASE PATIENTS
por: Dovern, E, et al.
Publicado: (2022)

Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease
por: Dovern, E., et al.
Publicado: (2023)

5599344 IMPACT OF HOSPITAL ADMISSION FOR VASO-OCCLUSIVE CRISIS ON HEALTH-RELATED QUALITY OF LIFE IN CHILDREN WITH SICKLE CELL DISEASE
por: Vuong, C., et al.
Publicado: (2023)

P1421: THE EFFECT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION ON CEREBRAL PERFUSION AND OXYGEN METABOLISM IN PATIENTS WITH SICKLE CELL DISEASE
por: Afzali-Hashemi, Liza, et al.
Publicado: (2023)

Incentive spirometry to prevent acute chest syndrome in adults with sickle cell disease; a randomized controlled trial
por: van Tuijn, Charlotte F.J., et al.
Publicado: (2020)

Vaso‐occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID‐19)
por: Nur, Erfan, et al.
Publicado: (2020)

5610845 A PHASE 1 STUDY OF CSL888 (HEMOPEXIN) IN ADULT PATIENTS WITH SICKLE CELL DISEASE
por: Biemond, B.J., et al.
Publicado: (2023)

Immune thrombocytopenia due to COVID‐19 during pregnancy
por: Tang, M.W., et al.
Publicado: (2020)

P1470: NATURAL HISTORY AND RATE OF PROGRESSION OF RETINOPATHY IN PATIENTS WITH SICKLE CELL DISEASE: AN 11-YEAR RETROSPECTIVE FOLLOW-UP ANALYSIS
por: Brandsen, R., et al.
Publicado: (2022)

Assessment of functional shunting in patients with sickle cell disease
por: Afzali-Hashemi, Liza, et al.
Publicado: (2022)

Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study
por: Brandsen, Rajani P., et al.
Publicado: (2023)

N-acetylcysteine reduces oxidative stress in sickle cell patients
por: Nur, Erfan, et al.
Publicado: (2012)

Circulating Iron in Patients with Sickle Cell Disease Mediates the Release of Neutrophil Extracellular Traps
por: Van Avondt, Kristof, et al.
Publicado: (2023)

5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
por: van Dijk, M.J., et al.
Publicado: (2023)

Cerebral oxygen metabolism in adults with sickle cell disease
por: Václavů, Lena, et al.
Publicado: (2020)

Impairment of Cerebrovascular Hemodynamics in Patients With Severe and Milder Forms of Sickle Cell Disease
por: Afzali-Hashemi, Liza, et al.
Publicado: (2021)

P1440: ASSESSING ADHERENCE TO EMERGENCY DEPARTMENT PROTOCOLS FOR SICKLE CELL DISEASE: IMPLICATIONS FOR QUALITY OF CARE
por: van Tuijn, Charlotte, et al.
Publicado: (2023)

Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease
por: Saraf, Santosh L., et al.
Publicado: (2019)

Incidence of Sars-COV-2 Infection in Sickle Cell Patients Presenting with a Painful Crisis, a 12 Month Prospective Cohort Study
por: Konté, Kadère, et al.
Publicado: (2021)

Incidence of SARS‐COV‐2 infection in sickle cell patients presenting with a painful crisis: A 12‐month prospective cohort study
por: Konté, Kadère, et al.
Publicado: (2021)

The impact of voxelotor treatment on leg ulcers in patients with sickle cell disease
por: Minniti, Caterina P., et al.
Publicado: (2021)

S278: CEREBRAL HEMODYNAMICS AND OXYGEN METABOLISM IN PATIENTS WITH MILD AND SEVERE SICKLE CELL DISEASE AND THALASSEMIA
por: Afzali-Hashemi, Liza, et al.
Publicado: (2023)

S279: EFFECT OF VOXELOTOR ON CEREBRAL PERFUSION AND CEREBRAL OXYGEN METABOLISM IN ADULT PATIENTS WITH SICKLE CELL DISEASE; THE COVERAGE STUDY
por: Konté, Kadère, et al.
Publicado: (2023)

Fluid overload due to intravenous fluid therapy for vaso‐occlusive crisis in sickle cell disease: incidence and risk factors
por: Gaartman, Aafke E., et al.
Publicado: (2021)

Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease
por: Václavů, Lena, et al.
Publicado: (2019)

PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
por: M., VAN DIJK, et al.
Publicado: (2022)

P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES
por: Konté, Kadère, et al.
Publicado: (2023)

Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review
por: Bhalla, Nishka, et al.
Publicado: (2023)

P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
por: van Dijk, M. J., et al.
Publicado: (2022)

Orthopaedic manifestations of sickle-cell disease.
por: Huo, M. H., et al.
Publicado: (1990)

The Role of Nutrition in Sickle Cell Disease
por: Hyacinth, H.I., et al.
Publicado: (2010)

Bilateral breast calciphylaxis in a patient who survived earlier extensive tissue necrosis 5 years previously: A case report
por: Verstappen, E.M.J., et al.
Publicado: (2018)

Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients
por: Jarduli‐Maciel, Luciana Ribeiro, et al.
Publicado: (2022)

PB2227: HEALTH-RELATED QUALITY OF LIFE OVER TIME IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE ADMITTED FOR VASO-OCCLUSIVE CRISIS.
por: Vuong, C., et al.
Publicado: (2022)

Fatal Dengue in Patients with Sickle Cell Disease or Sickle Cell Anemia in Curaçao: Two Case Reports
por: Moesker, Fleur M., et al.
Publicado: (2013)

S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL
por: Achebe, M, et al.
Publicado: (2022)

S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: Osunkwo, I, et al.
Publicado: (2022)

Patients’ and parents’ perspective on the implementation of Patient Reported Outcome Measures in pediatric clinical practice using the KLIK PROM portal
por: van Muilekom, Maud M., et al.
Publicado: (2021)

Correction to: Patients’ and parents’ perspective on the implementation of Patient Reported Outcome Measures in pediatric clinical practice using the KLIK PROM portal
por: van Muilekom, Maud M., et al.
Publicado: (2022)

Sickle cell, habitual dys-positions and fragile dispositions: young people with sickle cell at school
por: Dyson, Simon M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pe4tf61io8qig8qvpubnullpdm